Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat as a pancake but hopes still of Christmas rally
ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding
ASX Health Stocks: Chimeric jumps 35pc as cell therapy drug shows pre-clinical efficacy
Evolt 360 flexes muscles with transformative partnerships in global fitness arena
Weed Week: Massive study links cannabis to genetics and schizophrenia, and the best ASX weed stocks right now
‘Strongly positioned to move the business forward’: Race Oncology appoints new CEO
Alta Global acquires longest running MMA community platform ‘The Underground’
ASX Health Stocks: Mesoblast partners up for pivotal trial, Alterity in $4.8 million cap raise
Why this ASX biotech is primed to capitalise as big pharma flocks to the rare diseases market
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
REPORT: ASX wound care is rapidly becoming an ‘exciting subsector’
This company aims to disrupt the infant formula and dairy sector … with camel milk?
AdAlta’s latest results bolster safety profile and dose selection for primary asset, enhancing partnering, reducing Phase 2 trial risks
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
ASX Health Stocks: 4DX jumps 15pc after FDA clearance; while AI-focused biotechs TrivarX and Artrya also gain
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
ASX Health Stocks: Singular jumps 18pc after securing funds, Tax Office wipes smile off Pacific
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
